Tuberculosis - Annual Epidemiological Report for 2017
Thirty-one EU/EEA countries reported 55 337 TB cases, 10.7 per 100 000 population. The overall notification rate and most country-specific rates continued to fall. However, countries face a number of challenges in reaching the goal to end the TB epidemic.
Foreign-origin TB cases accounted for 33% of cases overall. In countries with TB notification rates higher than 10 per 100 000 population, 20% or less of cases were reported as being of foreign origin.
Multidrug resistance (MDR) was reported for 4% of cases tested overall and for 11–25% of the cases tested in the Baltic countries. Extensive drug resistance (XDR) was reported for 24% of MDR TB cases that underwent second-line drug susceptibility testing.
Treatment success was achieved in 71% of all TB cases, 63% of HIV-coinfected TB cases, 45% of MDR TB cases notified in 2015, and 28% of XDR TB cases notified in 2014.
The estimated TB mortality rate in the EU/EEA, excluding HIV deaths in co-infected TB cases, was 0.8 deaths per 100 000 population, with 4 000 estimated deaths overall.
Tuberculosis (TB) is a serious infectious disease that can be fatal. It most commonly affects the lungs.Read more
Disease data from ECDC Surveillance Atlas - tuberculosis
The Surveillance Atlas of Infectious Diseases is a tool that interacts with the latest available data about a number of infectious diseases. The interface allows users to interact and manipulate the data to produce a variety of tables and maps.Read more
All annual Epidemiological Reports (AERs)
The Annual Epidemiological Reports (AERs) are key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe. These reports give overviews of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union (EU) and European Economic Area (EEA) countries.Read more